Opiate maintenance with buprenorphine in ambulatory care: A 24-week follow-up study of new users

Drug and Alcohol Dependence

Volumn 72, Issue 3, 2003, Pages 297-303

  Lapeyre Mestre, M ^a   Llau, M E ^a   Gony, M ^a   Navel, A M ^b   Bez, J ^c   Grau, M ^c   Montastruc, J L ^a  

^a Ctr d'Eval d'Info Sur P   (France)

^b Haute Garonne Department   (France)

^c Health Insurance System   (France)

Author keywords

Addiction; Benzodiazepines; Buprenorphine; Maintenance treatment; Misuse; Retention rate

Indexed keywords

BENZODIAZEPINE; BUPRENORPHINE; OPIATE AGONIST;

ADULT; AMBULATORY CARE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DRUG DEPENDENCE TREATMENT; DRUG USE; FEMALE; FOLLOW UP; HEALTH CARE; HUMAN; INTERMETHOD COMPARISON; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PATIENT SELECTION; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0344440971     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2003.08.005     Document Type: Article

References (27)

1. Barnett P.G., Rodgers J.H., Bloch D.A. A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence. Addiction. 96:2001;683-690.
2. Barrau K., Thirion X., Micallef J., Chuniaud-Louche C., Bellemin B., San Marco J.L. Comparison of methadone and high dosage buprenorphine users in French care centres. Addiction. 96:2001;1433-1441.
3. Baumevieille M., Haramburu F., Bégaud B. Abuse of prescription medicines in southwestern France. Ann. Pharmacother. 31:1997;847-850.
4. De Ducla M., Gagnon A., Mucchielli A., Robinet S., Vellay A. Comparison of high dose buprenorphine treatments of opiate-dependent outpatients in four healthcare networks. Ann Med. Interne Paris. 151(Suppl. B):2000;B9-B15.
5. Duburcq A., Charpak Y., Blin P., Madec L. Two-years follow-up of heroin users treated by GPs with high dosage buprenorphine: the SPESUB study (pharmacoepidemiological follow-up of high dosage buprenorphine in general practice). Rev. Epidem. Sante. Pub. 48:2000;363-373.
6. Farré M., Mas A., Torrens M., Moreno V., Cami J. Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis. Drug Alcohol Depend. 65:2002;283-290.
7. ®). Ann. Med. Interne Paris. 152(Suppl. 3):2001;IS26-IS36.
8. Fischer G., Gombas W., Eder H., Jagsch R., Peternell A., Stuhlinger G., Pezawas L., Aschauer H.N., Kasper S. Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction. 94:1999;1337-1347.
9. Kintz P. Deaths involving buprenorphine: a compendium of French cases. Forensic Sci. Int. 121:2001;65-69.
10. Lapeyre-Mestre M., Damase-Michel C., Adams P., Michaud P., Montastruc J.L. Falsified or forged medical prescriptions as an indicator of pharmacodependence: a pilot study. Eur. J. Clin. Pharmacol. 52:1997;37-39.
11. Lapeyre-Mestre M., Llau E.L., Navel A.M., Bez J., Grau M., Montastruc J.L. A 24-week follow-up study of methadone and buprenorphine new users using data of a French prescription database. Drug Alcohol Depend. 66:2002;S99.
12. Ling W., Wesson D.R., Charuvastra C., Klett C.J. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch. Gen. Psychiatry. 53:1996;401-407.
13. Llau M.E., Lapeyre-Mestre M., Plas L., Damase-Michel C., Montastruc J.L. Forged medical prescriptions in a community pharmacists network in Midi-Pyrénées area: assessment of a falsification ratio. Eur. J. Clin. Pharmacol. 57:2002;911-912.
14. Mattick, R.P., Kimber, J., Breen, C., Davoli, M., 2002. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. The Cochrane Database of Systematic Reviews. The Cochrane Library Issue 4.
15. Moore N., Pierfitte C., Pehourcq F., Lagnaoui R., Begaud B. Comparison of patient questionnaires, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjects. Clin. Pharmacol. Ther. 69:2001;445-450.
16. Obadia Y., Perrin V., Feroni I., Vlahov D., Moatti J.P. Injecting misuse of buprenorphine among French drug users. Addiction. 96:2001;267-272.
17. Observatoire Français des Drogues et Toxicomanies (OFDT), 2002. Substitution aux opiacés dans cinq sites de France en 1999 et 2000: usagers et stratégies de traitements. OFDT, Paris.
18. O'Connor P.G., Fiellin D.A. Pharmacologic treatment of heroin-dependent patients. Ann. Intern. Med. 133:2000;40-54.
19. Pani P.P., Maremmani I., Piratsu R., Tagliamonte A., Gessa G.L. Buprenorphine: controlled clinical trial in the treatment of opioid dependence. Drug Alcohol Depend. 69:2000;39-50.
20. Reynaud M., Petit G., Potard D., Courty P. Six deaths linked to concomitant use of buprenorphine and benzodiazepines. Addiction. 93:1998;1385-1392.
21. Thirion X., Micallef J., Barrau K., Djezzar S., Sanmarco J.L., Lagier G. Observation of psychoactive substance consumption: methods and results of the French OPPIDUM programme. Eur. Addict Res. 7:2001a;32-36.
22. Thirion X., Micallef J., Barrau K., Djezzar S., Lambert H., Sanmarco J.L., Lagier G. Recent evolution in opiate dependence in France during generalisation of maintenance treatments. Drug Alcohol Depend. 61:2001b;281-285.
23. Thirion X., Lapierre V., Micallef J., Ronfle E., Masut A., Pradel V., Coudert C., Mabriez J.C., Sanmarco J.L. Buprenorphine prescription by general practitioners in a French region. Drug Alcohol Depend. 65:2002;197-204.
24. Tracqui A., Kintz P., Ludes B. Buprenorphine-related deaths among drug addicts in France a report on 20 fatalities. J. Anal. Toxicol. 22:1998;430-434.
25. Vignau J., Duhamel A., Catteau J., Legal G., Pho A.H., Grailles I., Beauvillain J., Petit P., Beauvillain P., Parquet P.J. Practice-based buprenorphine maintenance treatment (BMT): how do French healthcare providers manage the opiate-addicted patients? J. Subst. Abuse Treat. 21:2001;135-144.
26. West S.L., O'Neal K.K., Graham C.W. A meta-analysis comparing the effectiveness of buprenorphine and methadone. J. Subst. Abuse. 12:2000;405-414.
27. World Health Organization. WHO Expert Committee on Drug Dependence, 2001. Thirty-second report. World Health Organ. Tech. Rep. Ser. 903, 1-26.